Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
In China, 44 people became ill with an unknown form of pneumonia
In China, 44 people fell ill with an unknown form of pneumonia, condition 11 was assessed as severe, and 121 more were under surveillance.
Pfizer, BMS, Gilead, AbbVie and others hike prices on hundreds of meds to ring in 2020
It may be a new year, but an old tradition is playing out in the pharma world—the price-hiking tradition, that is.
FDA approves UVA-developed artificial pancreas
The U.
More January U.S. price hikes take 2020 tally to over 330 drugs with higher cost
NEW YORK (Reuters) - AbbVie Inc on Thursday raised the cost of rheumatoid arthritis treatment Humira, the world’s top-selling medicine, joining other drugmakers that have now hiked U.
Novo Nordisk to offer free insulin to U.S. patients in immediate need
(Reuters) - Novo Nordisk said on Thursday it would offer free, one-time supply of insulin to people in immediate need and at risk of rationing the medication, the rising price of which has att...
Artificial intelligence programme detects breast cancer better than experts, study finds
An AI system developed by Google Health can identify cancer in breast screening mammograms with fewer false positives and fewer false negatives than radiologistsA new study has found that an AI system...
Antibiotics maker Melinta files for Chapter 11 bankruptcy
(Reuters) - Melinta Therapeutics Inc said on Friday it had filed for bankruptcy protection, becoming the latest casualty of a persistent cash burn in the antibiotic industry.
China regulator approves imports of J&J's Tremfya
BEIJING (Reuters) - China has approved imports of Johnson & Johnson’s Tremfya (guselkumab), the National Medical Products Administration said in a notice on Friday.
Astellas Strengthens Immuno-oncology Pipeline with Acquisition of Xyphos Biosciences, Inc.
TOKYO and SOUTH SAN FRANCISCO, Calif.
GSK puts faith in AI to make more successful drugs more quickly
GlaxoSmithKline is ramping up its use of artificial intelligence and recruiting 80 AI specialists by the end of 2020 as it turns to cutting-edge computing to develop medicines of the future.
FDA approves first generics of Eliquis
The U.
AstraZeneca, Daiichi notch blockbuster FDA nod for breast cancer med Enhertu
Enhertu will be co-developed and sold by AstraZeneca and Daiichi, except in Japan where Daiichi owns sole rights.
334
335
336
337
338
339
340
341
342
